Comparison between gadopentetate and feruglose (Clariscan™)-enhanced MR-mammography: Preliminary clinical experience

Academic Radiology

Volumn 9, Issue SUPPL. 2, 2002, Pages

  Daldrup Link, Heike E ^a   Kaiser, Anna ^a   Link, Thomas M ^a   Settles, Marcus ^d   Helbich, Thomas ^b   Werner, Martin ^a   Roberts, Timothy P L ^c   Rummeny, Ernst J ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

FERUGLOSE; GADOLINIUM PENTETATE MEGLUMINE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM PENTETATE; IRON; OXIDE;

ADULT; AGED; BREAST DISEASE; BREAST TUMOR; CLINICAL ARTICLE; CONFERENCE PAPER; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MACROMOLECULE; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; ARTICLE; CHI SQUARE DISTRIBUTION; DIFFERENTIAL DIAGNOSIS; METHODOLOGY; MIDDLE AGED;

ADULT; AGED; BREAST NEOPLASMS; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; GADOLINIUM DTPA; HUMANS; IRON; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MIDDLE AGED; OXIDES;

EID: 0036333759     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1076-6332(03)80225-8     Document Type: Conference Paper

References (20)

1. Dynamic breast MR imaging: Are signal intensity time course data useful for differential diagnosis of enhancing lesions?
2. False positive cases in dynamic MR Mammography
3. Contrast enhanced MR imaging of the breast: Survey of 1200 patient examinations
4. Suspicious breast lesions: MR imaging with pathologic correlation
5. Correlation of dynamic contrast-enhanced magnetic resonance imaging with histologic tumor grade: Comparison of macromolecular and small molecular contrast media
6. Microvascular permeability of normal and neoplastic tissues
7. Transport of molecules across tumor vasculature
8. Vascular and interstitial barriers to delivery of therapeutic agents in tumors
9. MR imaging characterization of microvessels in experimental breast tumors by using a particulate contrast agent with histopathologic correlation
10. "NC100150 injection", a preparation of optimized iron oxide nanoparticles for positive contrast MR angiography
11. Value of blood pool contrast agents in magnetic resonance angiography of the pelvis and lower extremities
12. Safety and preliminary findings with the intravascular contrast agent NC100150 injection for MR coronary angiography
13. Myocardial perfusion using a new ultra small superparamagnetic iron oxide, enabling T2* perfusion with very short echo times: First trials in humans
14. Pharmacocinetics od Gd-DTPA / dimeglumine after intravenous injection into healthy volunteers
15. Characteristics of gadolinium-DTPA complex: A potential new NMR contrast agent
16. Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules
17. Barriers to drug delivery in solid tumors
18. Vascular permeability in a human tumor xenograft: Molecular size dependence and cutoff size
19. Tumor microvascular characterization using ultra small superparamagnetic iron oxide particles (USPIO) in an experimental breast cancer model
20. Physiologic measurements by contrast-enhanced MR imaging: Expectations and limitations